Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JANX | AMGN | GILD | BMY | VRTX |
| Company | Janux Therapeutics Inc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 54.11 | 262.18 | 92.62 | 56.93 | 403.14 |
| High | 55.39 | 263.58 | 92.83 | 57.12 | 409.60 |
| Low | 53.63 | 261.25 | 92.03 | 56.73 | 402.72 |
| Last | 55.49 | 263.21 | 92.39 | 57.25 | 407.58 |
| Change | +1.95 | +2.57 | +0.02 | +0.69 | +4.88 |
| % Change | +3.64% | +0.99% | +0.02% | +1.22% | +1.21% |
| Volume | 72,175 | 280,094 | 283,020 | 884,391 | 115,715 |
| 20-Day Average Volume | 1,147,682 | 3,652,550 | 6,627,181 | 10,839,265 | 1,827,853 |
| Previous Close | 53.54 | 260.64 | 92.37 | 56.56 | 402.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 59.05 | 267.48 | 92.42 | 57.33 | 437.39 |
| 20-Day Raw Stochastic | 13.67% | 35.88% | 57.82% | 36.97% | 31.36% |
| 20-Day Relative Strength | 49.75% | 34.90% | 52.71% | 50.10% | 36.77% |
| Weighted Alpha | -7.29 | -17.99 | +20.40 | +16.05 | -9.00 |
| Today's Opinion | 80% Buy | 88% Sell | 88% Buy | 72% Buy | 72% Sell |
| Previous Opinion | 64% Buy | 88% Sell | 88% Buy | 56% Buy | 72% Sell |
| Last Month's Opinion | 8% Buy | 72% Sell | 100% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.36% since 12/24/24 | -0.61% since 12/24/24 | -1.72% since 12/24/24 | -1.69% since 12/24/24 | +0.14% since 12/24/24 |
| Low | 52.14 on 12/30/24 | 258.50 on 12/30/24 | 91.72 on 12/30/24 | 55.93 on 12/31/24 | 399.06 on 12/30/24 |
| High | 55.97 on 12/26/24 | 264.73 on 12/26/24 | 94.55 on 12/26/24 | 58.38 on 12/27/24 | 411.29 on 12/26/24 |
| 1-Month | |||||
| %Chg | +36.42% since 12/02/24 | -5.47% since 12/02/24 | -1.80% since 12/02/24 | -5.26% since 12/02/24 | -12.23% since 12/02/24 |
| Low | 52.14 on 12/30/24 | 253.30 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 | 377.85 on 12/19/24 |
| High | 71.71 on 12/05/24 | 281.38 on 12/03/24 | 94.65 on 12/11/24 | 60.09 on 12/03/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | +26.16% since 10/02/24 | -17.78% since 10/02/24 | +8.96% since 10/02/24 | +5.63% since 10/02/24 | -11.55% since 10/02/24 |
| Low | 40.02 on 12/02/24 | 253.30 on 12/19/24 | 83.98 on 10/04/24 | 51.31 on 10/15/24 | 377.85 on 12/19/24 |
| High | 71.71 on 12/05/24 | 329.17 on 10/11/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +39.48% since 07/02/24 | -15.41% since 07/02/24 | +34.99% since 07/02/24 | +40.38% since 07/02/24 | -13.72% since 07/02/24 |
| Low | 34.51 on 08/08/24 | 253.30 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 | 377.85 on 12/19/24 |
| High | 71.71 on 12/05/24 | 346.85 on 07/25/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,809,886 | 140,102,608 | 115,117,592 | 114,713,688 | 103,706,928 |
| Shares Outstanding, K | 52,482 | 537,533 | 1,246,266 | 2,028,177 | 257,529 |
| Annual Sales | 8,080,000 | 28,190,000,000 | 27,116,000,000 | 45,006,000,000 | 9,869,200,000 |
| Annual Net Income | -58,290,000 | 6,717,000,000 | 5,665,000,000 | 8,025,000,000 | 3,619,600,000 |
| Last Quarter Sales | 440,000 | 8,503,000,000 | 7,545,000,000 | 11,892,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -28,060,000 | 2,830,000,000 | 1,253,000,000 | 1,211,000,000 | 1,045,400,000 |
| 60-Month Beta | 3.29 | 0.55 | 0.18 | 0.45 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.51 on 11/06/24 | 5.58 on 10/30/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 11/05/24 | 02/04/25 | 02/11/25 | 02/06/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.770 on 12/13/24 | 0.620 on 01/03/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 12/13/24 | 01/03/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.49 | 20.77 | 47.91 | 0.00 |